Releases

Chai disclosed Chai-3 as its most advanced molecular-design model through a licensing collaboration with Pfizer.

Chai Discovery introduced a model family for zero-shot de novo antibody, nanobody, and miniprotein design.

Chai Discovery released Chai-1 model weights and inference code under Apache 2.0, including commercial use.

Chai Discovery released a multimodal foundation model for unified molecular structure prediction across proteins, small molecules, DNA, RNA, and covalent modifications.